202 related articles for article (PubMed ID: 31563757)
1. Quantification of a cocrystal and its dissociated compounds in solid dosage form using transmission Raman spectroscopy.
Koide T; Takeuchi Y; Otaki T; Yamamoto K; Shimamura R; Ohashi R; Inoue M; Fukami T; Izutsu KI
J Pharm Biomed Anal; 2020 Jan; 177():112886. PubMed ID: 31563757
[TBL] [Abstract][Full Text] [Related]
2. Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy.
Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
J Pharm Biomed Anal; 2018 Sep; 158():214-224. PubMed ID: 29886369
[TBL] [Abstract][Full Text] [Related]
3. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression.
Kachrimanis K; Braun DE; Griesser UJ
J Pharm Biomed Anal; 2007 Jan; 43(2):407-12. PubMed ID: 16935450
[TBL] [Abstract][Full Text] [Related]
5. Solid-State Quantification of Cocrystals in Pharmaceutical Tablets Using Transmission Low-Frequency Raman Spectroscopy.
Inoue M; Osada T; Hisada H; Koide T; Fukami T; Roy A; Carriere J; Heyler R
Anal Chem; 2019 Nov; 91(21):13427-13432. PubMed ID: 31565923
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms
Belay NF; Busche S; Manici V; Shaukat M; Arndt SO; Schmidt C
Eur J Pharm Sci; 2021 Nov; 166():105963. PubMed ID: 34352284
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical quantification with univariate analysis using transmission Raman spectroscopy.
Shimamura R; Koide T; Hisada H; Inoue M; Fukami T; Katori N; Goda Y
Drug Dev Ind Pharm; 2019 Sep; 45(9):1430-1436. PubMed ID: 31104513
[TBL] [Abstract][Full Text] [Related]
8. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance.
Ullah M; Hussain I; Sun CC
Drug Dev Ind Pharm; 2016; 42(6):969-76. PubMed ID: 26460090
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Approach to Screen the Capability of Raman and Infrared (Mid- and Near-) Spectroscopy for Quantification of Low-Active Pharmaceutical Ingredient Content Solid Dosage Forms: The Case of Alprazolam.
Makraduli L; Makreski P; Goracinova K; Stefov S; Anevska M; Geskovski N
Appl Spectrosc; 2020 Jun; 74(6):661-673. PubMed ID: 32031007
[TBL] [Abstract][Full Text] [Related]
10. Understanding impact of pre-dissolved polymers on dissolution behavior of soluble carbamazepine cocrystal.
Ullah M; Khan SA; Shah SM; Rabbani I; Sadozai SK; Abbas N; Bin Asad MHH; Badshah M; Hasan SMF; Hussain I
Pak J Pharm Sci; 2019 May; 32(3):1049-1055. PubMed ID: 31278719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
[TBL] [Abstract][Full Text] [Related]
12. Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation.
Ullah M; Shah MR; Bin Asad MHH; Hasan SMF; Hussain I
Pak J Pharm Sci; 2017 Nov; 30(6):2139-2145. PubMed ID: 29175782
[TBL] [Abstract][Full Text] [Related]
13. RELATIVE BIOAVAILABILITY STUDY OF SUCCINIC ACID COCRYSTAL TABLET AND MARKETED CONVENTIONAL IMMEDIATE RELEASE TABLET FORMULATION OF CARBAMAZEPINE 200 MG IN RABBITS.
Ullah M; Murtaza G; Hussain I
Acta Pol Pharm; 2016 Jul; 73(4):1023-1027. PubMed ID: 29648728
[TBL] [Abstract][Full Text] [Related]
14. Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.
Barakh Ali SF; Rahman Z; Dharani S; Afrooz H; Khan MA
J Pharm Sci; 2019 Mar; 108(3):1211-1219. PubMed ID: 30773201
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the Sensitivity of Transmission Raman Spectroscopy for Polymorph Detection in Pharmaceutical Tablets.
Feng H; Bondi RW; Anderson CA; Drennen JK; Igne B
Appl Spectrosc; 2017 Aug; 71(8):1856-1867. PubMed ID: 28357920
[TBL] [Abstract][Full Text] [Related]
16. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy.
Kang Y; Shao Z; Wang Q; Hu X; Yu D
J Pharm Biomed Anal; 2018 Sep; 158():28-37. PubMed ID: 29857267
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry.
Liu M; Liu J; Wang Q; Song P; Li H; Wu S; Gong J
Spectrochim Acta A Mol Biomol Spectrosc; 2023 May; 293():122458. PubMed ID: 36801728
[TBL] [Abstract][Full Text] [Related]
19. Comparison of NIR chemical imaging with conventional NIR, Raman and ATR-IR spectroscopy for quantification of furosemide crystal polymorphs in ternary powder mixtures.
Schönbichler SA; Bittner LK; Weiss AK; Griesser UJ; Pallua JD; Huck CW
Eur J Pharm Biopharm; 2013 Aug; 84(3):616-25. PubMed ID: 23395969
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Monitoring of Cocrystal Polymorphisms in Model Tablets Using Transmission Low-Frequency Raman Spectroscopy.
Inoue M; Osada T; Hisada H; Koide T; Fukami T; Roy A; Carriere J
J Pharm Sci; 2023 Jan; 112(1):225-229. PubMed ID: 36126759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
